Molecular and computational analyses for improved clinical decision making in acute myeloid leukemia

The overall aim of this project is to improve clinical decision making of patients diagnosed with acute myeloid leukemia (AML) by applying high-throughput molecular and computational analyses. The results will be used to refine diagnostics, classification and treatment selection of patients diagnosed with AML.